Table 4 Prevalence, number of edges, degree and betweenness centrality of diseases by gender and multimorbidity clusters in the population with ≥ 3 chronic conditions
From: Reducing complexity: a visualisation of multimorbidity by combining disease clusters and triads
ADS and pain | Prevalence in patients | Number of edges (degree centrality) | Betweenness centrality | ||||
|---|---|---|---|---|---|---|---|
Total | Females | Males | Females | Males | Females | Males | |
Chronic low back pain | 43.7% | 47.1% | 41.0% | 16 (8.0%) | 16 (9.2%) | 28.4% | 32.2% |
Joint arthrosis | 28.7% | 33.6% | 24.8% | 10 (5.0%) | 9 (5.2%) | 4.9% | 5.7% |
Lower limb varicosis | 16.4% | 22.7% | 11.5% | 7 (3.5%) | 2 (1.1%) | 3.1% | 0.0% |
Prostatic hyperplasia | * | - | 28.1% | - | 5 (2.9%) | - | 2.6% |
Asthma/COPD | 15.3% | 14.1% | 16.3% | 3 (1.5%) | 4 (2.3%) | 0.4% | 0.1% |
Depression | 12.4% | 18.1% | 7.8% | 10 (5.0%) | 2 (1.1%) | 11.9% | 0.0% |
Chronic gastritis/GERD | 10.8% | 10.8% | 10.8% | 7 (3.5%) | 3 (1.7%) | 2.7% | 0.1% |
Osteoporosis | 10.7% | 19.7% | 3.6% | 2 (1.0%) | - | 0.0% | - |
Gynaecological problems | * | 16.6% | - | 3 (1.5%) | - | 0.1% | - |
Allergies | 7.3% | 8.5% | 6.3% | 3 (1.5%) | - | 0.4% | - |
Insomnia | 6.6% | 7.6% | 5.8% | 4 (2.0%) | 2 (1.1%) | 0.2% | 0.0% |
Intestinal diverticulosis | 6.3% | 6.4% | 6.2% | 2 (1.0%) | 2 (1.1%) | 0.0% | 0.0% |
Hemorrhoids | 6.1% | 5.2% | 6.8% | 2 (1.0%) | 4 (2.3%) | 0.0% | 0.4% |
Somatoform disorders | 5.9% | 7.7% | 4.5% | 5 (2.5%) | - | 1.1% | - |
Severe hearing loss | 4.6% | 3.8% | 5.2% | - | 2 (1.1%) | - | 0.0% |
Dizziness | 4.2% | 5.4% | 3.4% | 2 (1.0%) | - | 0.0% | - |
Anxiety | 2.5% | 3.7% | 1.6% | 2 (1.0%) | - | 0.0% | - |
Sexual dysfunction | * | - | 4.5% | - | 2 (1.1%) | - | 0.0% |
Cardiovascular and metabolic | |||||||
Hypertension | 69.3% | 69.3% | 69.4% | 13 (6.5%) | 9 (5.2%) | 12.0% | 12.0% |
Lipid metabolism disorders | 47.4% | 46.7% | 48.0% | 11 (5.5%) | 8 (4.6%) | 5.8% | 1.4% |
Diabetes mellitus | 28.5% | 24.9% | 31.4% | 14 (7.0%) | 11 (6.3%) | 5.8% | 5.0% |
Chronic ischemic heart disease | 25.7% | 18.2% | 31.6% | 13 (6.5%) | 10 (5.7%) | 5.1% | 2.8% |
Hyperuricemia/Gout | 18.1% | 11.3% | 23.5% | 11 (5.5%) | 12 (6.9%) | 5.2% | 7.8% |
Cardiac arrhythmias | 18.0% | 15.5% | 20.0% | 6 (3.0%) | 8 (4.6%) | 0.2% | 4.3% |
Atherosclerosis/PAOD | 13.7% | 10.3% | 16.4% | 8 (4.0%) | 10 (5.7%) | 2.6% | 5.7% |
Obesity | 12.4% | 13.4% | 11.7% | 9 (4.5%) | 7 (4.0%) | 2.2% | 3.8% |
Liver diseases | 12.0% | 9.9% | 13.7% | 7 (3.5%) | 8 (4.6%) | 2.0% | 4.5% |
Cardiac insufficiency | 9.0% | 10.1% | 8.1% | 8 (4.0%) | 8 (4.6%) | 1.0% | 1.3% |
Cerebral ischemia/Chronic stroke | 9.0% | 7.3% | 10.3% | 2 (1.0%) | 4 (2.3%) | 0.0% | 0.1% |
Neuropathies | 8.2% | 8.1% | 8.2% | 7 (3.5%) | 6 (3.4%) | 4.6% | 3.9% |
Renal insufficiency | 6.5% | 4.2% | 8.3% | 4 (2.0%) | 9 (5.2%) | 0.0% | 2.6% |
Cardiac valve disorders | 5.7% | 5.2% | 6.0% | 4 (2.0%) | 5 (2.9%) | 0.1% | 2.2% |
No multimorbidity pattern | |||||||
Severe vision reduction | 20.6% | 22.0% | 19.6% | 3 (1.5%) | 2 (1.1%) | 0.1% | 0.0% |
Cancers | 18.4% | 14.8% | 21.2% | - | 2 (1.1%) | - | 0.0% |
Urinary incontinence | 5.1% | 7.1% | 3.5% | 2 (1.0%) | 2 (1.1%) | 0.0% | 0.0% |